SCOP Search:   
        by sunid, keyword
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(use 'Shift Left-Click' to collapse/expand all levels downwards; use 'Control Left-Click' to collapse/expand all levels upwards)
 
(-)
Class: Alpha and beta proteins (a+b) (23004)
(-)
Fold: Protein kinase-like (PK-like) (2589)
(-)
Superfamily: Protein kinase-like (PK-like) (2589)
(-)
Family: automated matches (529)
(-)
Protein domain: automated matches (529)
(-)
Human (Homo sapiens) [TaxId: 9606] (438)
1X8BA:STRUCTURE OF HUMAN WEE1A KINASE: KINASE DOMAIN COMPLEXED WITH INHIBITOR PD0407824
1YI6A:; B:C-TERM TAIL SEGMENT OF HUMAN TYROSINE KINASE (258-533)
1YOJA:; B:CRYSTAL STRUCTURE OF SRC KINASE DOMAIN
1YOLA:; B:CRYSTAL STRUCTURE OF SRC KINASE DOMAIN IN COMPLEX WITH CGP77675
1YOMA:; B:CRYSTAL STRUCTURE OF SRC KINASE DOMAIN IN COMPLEX WITH PURVALANOL A
1YRPA:; B:CATALYTIC DOMAIN OF HUMAN ZIP KINASE PHOSPHORYLATED AT THR265
1YVJA:CRYSTAL STRUCTURE OF THE JAK3 KINASE DOMAIN IN COMPLEX WITH A STAUROSPORINE ANALOGUE
1ZRZA:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF ATYPICAL PROTEIN KINASE C-IOTA
2A19B:; C:PKR KINASE DOMAIN- EIF2ALPHA- AMP-PNP COMPLEX.
2A1AB:PKR KINASE DOMAIN-EIF2ALPHA COMPLEX
2A2AA:; B:; C:; D:HIGH-RESOLUTION CRYSTALLOGRAPHIC ANALYSIS OF THE AUTOINHIBITED CONFORMATION OF A HUMAN DEATH-ASSOCIATED PROTEIN KINASE
2AC3A:STRUCTURE OF HUMAN MNK2 KINASE DOMAIN
2B7AA:; B:THE STRUCTURAL BASIS OF JANUS KINASE 2 INHIBITION BY A POTENT AND SPECIFIC PAN-JANUS KINASE INHIBITOR
2BIKB:HUMAN PIM1 PHOSPHORYLATED ON SER261
2BMCA:; B:; C:; D:; E:; F:AURORA-2 T287D T288D COMPLEXED WITH PHA-680632
2BUJA:; B:CRYSTAL STRUCTURE OF THE HUMAN SERINE-THREONINE KINASE 16 IN COMPLEX WITH STAUROSPORINE
2BVAA:; B:CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 4
2BZHB:CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH A RUTHENIUM ORGANOMETALLIC LIGAND RU1
2BZIB:CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH A RUTHENIUM ORGANOMETALLIC LIGAND RU2
2BZJA:CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH A RUTHENIUM ORGANOMETALLIC LIGAND RU3
2C30A:CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 6
2CDZA:CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 4 IN COMPLEX WITH CGP74514A
2CKEA:; B:; C:; D:HUMAN DEATH-ASSOCIATED DRP-1 KINASE IN COMPLEX WITH INHIBITOR
2CLQA:; B:STRUCTURE OF MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 5
2CN5A:CRYSTAL STRUCTURE OF HUMAN CHK2 IN COMPLEX WITH ADP
2CN8A:CRYSTAL STRUCTURE OF HUMAN CHK2 IN COMPLEX WITH DEBROMOHYMENIALDISINE
2DQ7X:CRYSTAL STRUCTURE OF FYN KINASE DOMAIN COMPLEXED WITH STAUROSPORINE
2DYLA:CRYSTAL STRUCTURE OF HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 7 ACTIVATED MUTANT (S287D, T291D)
2F57A:; B:CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 5
2GSFA:THE HUMAN EPHA3 RECEPTOR TYROSINE KINASE AND JUXTAMEMBRANE REGION
2H6DA:PROTEIN KINASE DOMAIN OF THE HUMAN 5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2 (AMPK ALPHA-2 CHAIN)
2HW6A:; B:CRYSTAL STRUCTURE OF MNK1 CATALYTIC DOMAIN
2HW7A:CRYSTAL STRUCTURE OF MNK2-D228G IN COMPLEX WITH STAUROSPORINE
2I6LA:; B:CRYSTAL STRUCTURE OF HUMAN MITOGEN ACTIVATED PROTEIN KINASE 6 (MAPK6)
2IN6A:WEE1 KINASE COMPLEX WITH INHIBITOR PD311839
2IO6A:WEE1 KINASE COMPLEXED WITH INHIBITOR PD330961
2IVSA:; B:CRYSTAL STRUCTURE OF NON-PHOSPHORYLATED RET TYROSINE KINASE DOMAIN
2IVTA:CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN
2IVUA:CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN COMPLEXED WITH THE INHIBITOR ZD6474
2IVVA:CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN COMPLEXED WITH THE INHIBITOR PP1
2IWIA:; B:CRYSTAL STRUCTURE OF THE HUMAN PIM2 IN COMPLEX WITH A RUTHENIUM ORGANOMETALLIC LIGAND RU1
2J0IA:CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 4
2J2IB:CRYSTAL STRUCTURE OF THE HUMAB PIM1 IN COMPLEX WITH LY333531
2J4ZA:; B:STRUCTURE OF AURORA-2 IN COMPLEX WITH PHA-680626
2J50A:; B:STRUCTURE OF AURORA-2 IN COMPLEX WITH PHA-739358
2OU7A:STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN POLO-LIKE KINASE 1
2OWBA:STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN POLO-LIKE KINASE 1
2Q0NA:STRUCTURE OF HUMAN P21 ACTIVATING KINASE 4 (PAK4) IN COMPLEX WITH A CONSENSUS PEPTIDE
2QLUA:CRYSTAL STRUCTURE OF ACTIVIN RECEPTOR TYPE II KINASE DOMAIN FROM HUMAN
2QO2A:HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, DEPHOSPHORYLATED, APO STRUCTURE
2QO7A:HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, DEPHOSPHORYLATED, AMP-PNP BOUND
2QO9A:HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, PHOSPHORYLATED, AMP-PNP BOUND
2QOBA:HUMAN EPHA3 KINASE DOMAIN, BASE STRUCTURE
2QOCA:HUMAN EPHA3 KINASE DOMAIN, PHOSPHORYLATED, AMP-PNP BOUND STRUCTURE
2QODA:HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y602F MUTANT
2QOFA:HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y596F MUTANT
2QOIA:HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y596F:Y602F DOUBLE MUTANT
2QOKA:HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y596F:Y602F:S768A TRIPLE MUTANT
2QOLA:HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y596:Y602:S768G TRIPLE MUTANT
2QONA:HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y596F:Y602F:Y742A TRIPLE MUTANT
2QOOA:HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y596F:Y602F:Y742F TRIPLE MUTANT
2QOQA:HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, BASE, AMP-PNP BOUND STRUCTURE
2R4BA:; B:ERBB4 KINASE DOMAIN COMPLEXED WITH A THIENOPYRIMIDINE INHIBITOR
2RKUA:STRUCTURE OF PLK1 IN COMPLEX WITH BI2536
2V7OA:CRYSTAL STRUCTURE OF HUMAN CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE II GAMMA
2VN9A:; B:CRYSTAL STRUCTURE OF HUMAN CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II DELTA ISOFORM 1, CAMKD
2VWIA:; B:; C:; D:STRUCTURE OF THE OSR1 KINASE, A HYPERTENSION DRUG TARGET
2VWUA:EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
2VWVA:EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
2VWWA:EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
2VWXA:EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
2VWYA:EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
2VWZA:EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
2VX0A:EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
2VX1A:EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
2VZ6A:; B:STRUCTURE OF HUMAN CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE TYPE II ALPHA (CAMK2A) IN COMPLEX WITH INDIRUBIN E804
2W0JA:CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH NSC 109555, A SPECIFIC INHIBITOR
2W1IA:; B:STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR
2W7XA:CELLULAR INHIBITION OF CHECKPOINT KINASE 2 AND POTENTIATION OF CYTOTOXIC DRUGS BY NOVEL CHK2 INHIBITOR PV1019
2WELA:CRYSTAL STRUCTURE OF SU6656-BOUND CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE II DELTA IN COMPLEX WITH CALMODULIN
2WQMA:STRUCTURE OF APO HUMAN NEK7
2WQNA:STRUCTURE OF ADP-BOUND HUMAN NEK7
2WTCA:CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR
2WTDA:CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR
2WTIA:CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR
2WTJA:CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR
2WTKC:47-310; F:45-310STRUCTURE OF THE HETEROTRIMERIC LKB1-STRADALPHA-MO25ALPHA COMPLEX
2X2KA:CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN WITH INHIBITOR
2X2LA:CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN WITH INHIBITOR
2X2MA:; B:CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN WITH INHIBITOR
2X4FA:THE CRYSTAL STRUCTURE OF THE HUMAN MYOSIN LIGHT CHAIN KINASE LOC340156.
2X4ZA:CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 4 IN COMPLEX WITH PF-03758309
2X7FA:; B:; C:; D:; E:CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN TRAF2- AND NCK-INTERACTING KINASE WITH WEE1CHK1 INHIBITOR
2X9EA:HUMAN MPS1 IN COMPLEX WITH NMS-P715
2X9FA:EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
2XA4A:; B:INHIBITORS OF JAK2 KINASE DOMAIN
2XB7A:STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH NVP-TAE684
2XBAA:STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH PHA-E429
2XBJA:CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR
2XIKA:STRUCTURE OF HUMAN YSK1 (YEAST SPS1-STE20-RELATED KINASE 1)
2XK9A:STRUCTURAL ANALYSIS OF CHECKPOINT KINASE 2 (CHK2) IN COMPLEX WITH INHIBITOR PV1533
2XM9A:STRUCTURE OF A SMALL MOLECULE INHIBITOR WITH THE KINASE DOMAIN OF CHK2
2XP2A:STRUCTURE OF THE HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH CRIZOTINIB (PF-02341066)
2XVDA:EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
2Y7JA:; B:; C:; D:STRUCTURE OF HUMAN PHOSPHORYLASE KINASE, GAMMA 2
2YACA:CRYSTAL STRUCTURE OF POLO-LIKE KINASE 1 IN COMPLEX WITH NMS-P937
2YCFA:CRYSTAL STRUCTURE OF CHECKPOINT KINASE 2 IN COMPLEX WITH INHIBITOR PV1531
2YCQA:CRYSTAL STRUCTURE OF CHECKPOINT KINASE 2 IN COMPLEX WITH INHIBITOR PV1115
2YCRA:CRYSTAL STRUCTURE OF CHECKPOINT KINASE 2 IN COMPLEX WITH INHIBITOR PV976
2YCSA:CRYSTAL STRUCTURE OF CHECKPOINT KINASE 2 IN COMPLEX WITH PV788
2YFXA:STRUCTURE OF L1196M MUTANT ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH CRIZOTINIB
2YHVA:STRUCTURE OF L1196M MUTANT ANAPLASTIC LYMPHOMA KINASE
2YIQA:STRUCTURAL ANALYSIS OF CHECKPOINT KINASE 2 IN COMPLEX WITH INHIBITOR PV1322
2YIRA:STRUCTURAL ANALYSIS OF CHECKPOINT KINASE 2 IN COMPLEX WITH INHIBITOR PV1352
2YITA:STRUCTURAL ANALYSIS OF CHECKPOINT KINASE 2 IN COMPLEX WITH PV1162, A NOVEL INHIBITOR
2YJRA:STRUCTURE OF F1174L MUTANT ANAPLASTIC LYMPHOMA KINASE
2YJSA:STRUCTURE OF C1156Y MUTANT ANAPLASTIC LYMPHOMA KINASE
2YN8A:; B:EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
2YZAA:CRYSTAL STRUCTURE OF KINASE DOMAIN OF HUMAN 5'-AMP-ACTIVATED PROTEIN KINASE ALPHA-2 SUBUNIT MUTANT (T172D)
2Z2WA:HUMAN WEE1 KINASE COMPLEXED WITH INHIBITOR PF0335770
2Z7QA:CRYSTAL STRUCTURE OF THE N-TERMINAL KINASE DOMAIN OF HUMAN RSK-1 BOUND TO AMP-PCP
2Z7RA:CRYSTAL STRUCTURE OF THE N-TERMINAL KINASE DOMAIN OF HUMAN RSK1 BOUND TO STAUROSPORINE
2Z7SA:CRYSTAL STRUCTURE OF THE N-TERMINAL KINASE DOMAIN OF HUMAN RSK1 BOUND TO PURVALNOL A
2ZMCA:CRYSTAL STRUCTURE OF HUMAN MITOTIC CHECKPOINT KINASE MPS1 CATALYTIC DOMAIN APO FORM
2ZMDA:CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN T686A MUTANT IN COMPLEX WITH SP600125 INHIBITOR
2ZV2A:CRYSTAL STRUCTURE OF HUMAN CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 2, BETA, CAMKK2 KINASE DOMAIN IN COMPLEX WITH STO-609
3A60A:; B:CRYSTAL STRUCTURE OF UNPHOSPHORYLATED P70S6K1 (FORM I)
3A62A:CRYSTAL STRUCTURE OF PHOSPHORYLATED P70S6K1
3A7FA:HUMAN MST3 KINASE
3A7GA:; B:HUMAN MST3 KINASE
3A7HA:; B:HUMAN MST3 KINASE IN COMPLEX WITH ATP
3A7IA:HUMAN MST3 KINASE IN COMPLEX WITH ADENINE
3A7JA:HUMAN MST3 KINASE IN COMPLEX WITH MNADP
3A8WA:; B:CRYSTAL STRUCTURE OF PKCIOTA KINASE DOMAIN
3A8XA:; B:CRYSTAL STRUCTURE OF PKCIOTA KINASE DOMAIN
3ALNA:; B:; C:CRYSTAL STRUCTURE OF HUMAN NON-PHOSPHORYLATED MKK4 KINASE DOMAIN COMPLEXED WITH AMP-PNP
3AOXA:X-RAY CRYSTAL STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH CH5424802
3AQVA:HUMAN AMP-ACTIVATED PROTEIN KINASE ALPHA 2 SUBUNIT KINASE DOMAIN (T172D) COMPLEXED WITH COMPOUND C
3BHHA:; B:; C:; D:CRYSTAL STRUCTURE OF HUMAN CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE IIB ISOFORM 1 (CAMK2B)
3BHYA:CRYSTAL STRUCTURE OF HUMAN DEATH ASSOCIATED PROTEIN KINASE 3 (DAPK3) IN COMPLEX WITH A BETA-CARBOLINE LIGAND
3BI6A:WEE1 KINASE COMPLEX WITH INHIBITOR PD352396
3BIZA:WEE1 KINASE COMPLEX WITH INHIBITOR PD331618
3BLQA:CRYSTAL STRUCTURE OF HUMAN CDK9/CYCLINT1 IN COMPLEX WITH ATP
3BLRA:CRYSTAL STRUCTURE OF HUMAN CDK9/CYCLINT1 IN COMPLEX WITH FLAVOPIRIDOL
3BQRA:CRYSTAL STRUCTURE OF HUMAN DEATH ASSOCIATED PROTEIN KINASE 3 (DAPK3) IN COMPLEX WITH AN IMIDAZO-PYRIDAZINE LIGAND
3C0GA:; B:CASK CAM-KINASE DOMAIN- 3'-AMP COMPLEX, P1 FORM
3C0HA:; B:CASK CAM-KINASE DOMAIN- AMPPNP COMPLEX, P1 FORM
3C0IA:CASK CAM-KINASE DOMAIN- 3'-AMP COMPLEX, P212121 FORM
3C4CA:; B:B-RAF KINASE IN COMPLEX WITH PLX4720
3CEKA:CRYSTAL STRUCTURE OF HUMAN DUAL SPECIFICITY PROTEIN KINASE (TTK)
3CKWA:CRYSTAL STRUCTURE OF STERILE 20-LIKE KINASE 3 (MST3, STK24)
3CKXA:CRYSTAL STRUCTURE OF STERILE 20-LIKE KINASE 3 (MST3, STK24) IN COMPLEX WITH STAUROSPORINE
3COKA:; B:CRYSTAL STRUCTURE OF PLK4 KINASE
3COMA:; B:CRYSTAL STRUCTURE OF MST1 KINASE
3CQEA:WEE1 KINASE COMPLEX WITH INHIBITOR PD074291
3CR0A:WEE1 KINASE COMPLEX WITH INHIBITOR PD259_809
3DAKA:; B:; C:; D:CRYSTAL STRUCTURE OF DOMAIN-SWAPPED OSR1 KINASE DOMAIN
3DBQA:CRYSTAL STRUCTURE OF TTK KINASE DOMAIN
3DBSA:726-1091STRUCTURE OF PI3K GAMMA IN COMPLEX WITH GDC0941
3DLSA:; B:; C:; D:; E:; F:CRYSTAL STRUCTURE OF HUMAN PAS KINASE BOUND TO ADP
3DTCA:CRYSTAL STRUCTURE OF MIXED-LINEAGE KINASE MLK1 COMPLEXED WITH COMPOUND 16
3DZQA:HUMAN EPHA3 KINASE DOMAIN IN COMPLEX WITH INHIBITOR AWL-II-38.3
3E62A:FRAGMENT BASED DISCOVERY OF JAK-2 INHIBITORS
3E63A:FRAGMENT BASED DISCOVERY OF JAK-2 INHIBITORS
3E64A:FRAGMENT BASED DISCOVERY OF JAK-2 INHIBITORS
3ENMA:; B:; C:; D:THE STRUCTURE OF THE MAP2K MEK6 REVEALS AN AUTOINHIBITORY DIMER
3EYGA:CRYSTAL STRUCTURES OF JAK1 AND JAK2 INHIBITOR COMPLEXES
3EYHA:CRYSTAL STRUCTURES OF JAK1 AND JAK2 INHIBITOR COMPLEXES
3FC2A:PLK1 IN COMPLEX WITH BI6727
3FMEA:CRYSTAL STRUCTURE OF HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 6 (MEK6) ACTIVATED MUTANT (S207D, T211D)
3FUPA:; B:CRYSTAL STRUCTURES OF JAK1 AND JAK2 INHIBITOR COMPLEXES
3GFWA:CRYSTAL STRUCTURE OF HUMAN DUAL SPECIFICITY PROTEIN KINASE (TTK) IN COMPLEX WITH A PYROLO-PYRIDIN LIGAND
3GGFA:; B:CRYSTAL STRUCTURE OF HUMAN SERINE/THREONINE-PROTEIN KINASE MST4 IN COMPLEX WITH AN QUINAZOLIN
3H9FA:CRYSTAL STRUCTURE OF HUMAN DUAL SPECIFICITY PROTEIN KINASE (TTK) IN COMPLEX WITH A PYRIMIDO-DIAZEPIN LIGAND
3H9OA:PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1 (PDK-1) IN COMPLEX WITH COMPOUND 9
3HMNA:CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH ATP
3HMOA:CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH THE INHIBITOR STAUROSPORINE
3HMPA:CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH A QUINAZOLIN LIGAND COMPOUND 4
3HRCA:CRYSTAL STRUCTURE OF A MUTANT OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH ATP
3HRFA:CRYSTAL STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH AN ALLOSTERIC ACTIVATOR BOUND TO THE PIF-POCKET
3IO7A:2-AMINOPYRAZOLO[1,5-A]PYRIMIDINES AS POTENT AND SELECTIVE INHIBITORS OF JAK2
3IOKA:2-AMINOPYRAZOLO[1,5-A]PYRIMIDINES AS POTENT AND SELECTIVE INHIBITORS OF JAK2
3JY9A:JANUS KINASE 2 INHIBITORS
3KB7A:CRYSTAL STRUCTURE OF POLO-LIKE KINASE 1 IN COMPLEX WITH A PYRAZOLOQUINAZOLINE INHIBITOR
3KCKA:A NOVEL CHEMOTYPE OF KINASE INHIBITORS
3KEXA:; B:CRYSTAL STRUCTURE OF THE CATALYTICALLY INACTIVE KINASE DOMAIN OF THE HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 3 (HER3)
3KMUA:CRYSTAL STRUCTURE OF THE ILK/ALPHA-PARVIN CORE COMPLEX (APO)
3KMWA:CRYSTAL STRUCTURE OF THE ILK/ALPHA-PARVIN CORE COMPLEX (MGATP)
3KRRA:CRYSTAL STRUCTURE OF JAK2 COMPLEXED WITH A POTENT QUINOXALINE ATP SITE INHIBITOR
3L9PA:CRYSTAL STRUCTURE OF THE ANAPLASTIC LYMPHOMA KINASE CATALYTIC DOMAIN
3LCSA:CRYSTAL STRUCTURE OF THE ANAPLASTIC LYMPHOMA KINASE CATALYTIC DOMAIN
3LCTA:CRYSTAL STRUCTURE OF THE ANAPLASTIC LYMPHOMA KINASE CATALYTIC DOMAIN
3LM0A:CRYSTAL STRUCTURE OF HUMAN SERINE/THREONINE KINASE 17B (STK17B)
3LM5A:CRYSTAL STRUCTURE OF HUMAN SERINE/THREONINE KINASE 17B (STK17B) IN COMPLEX WITH QUERCETIN
3LMGA:; B:CRYSTAL STRUCTURE OF THE ERBB3 KINASE DOMAIN IN COMPLEX WITH AMP-PNP
3LPBA:; B:CRYSTAL STRUCTURE OF JAK2 COMPLEXED WITH A POTENT 2,8-DIARYL-QUINOXALINE INHIBITOR
3LXKA:STRUCTURAL AND THERMODYNAMIC CHARACTERIZATION OF THE TYK2 AND JAK3 KINASE DOMAINS IN COMPLEX WITH CP-690550 AND CMP-6
3LXLA:STRUCTURAL AND THERMODYNAMIC CHARACTERIZATION OF THE TYK2 AND JAK3 KINASE DOMAINS IN COMPLEX WITH CP-690550 AND CMP-6
3LXNA:STRUCTURAL AND THERMODYNAMIC CHARACTERIZATION OF THE TYK2 AND JAK3 KINASE DOMAINS IN COMPLEX WITH CP-690550 AND CMP-6
3LXPA:STRUCTURAL AND THERMODYNAMIC CHARACTERIZATION OF THE TYK2 AND JAK3 KINASE DOMAINS IN COMPLEX WITH CP-690550 AND CMP-6
3LZBA:; B:; C:; D:EGFR KINASE DOMAIN COMPLEXED WITH AN IMIDAZO[2,1-B]THIAZOLE INHIBITOR
3MFRA:CASK-4M CAM KINASE DOMAIN, NATIVE
3MFSA:CASK-4M CAM KINASE DOMAIN, AMPPNP
3MFTA:CASK-4M CAM KINASE DOMAIN, MN2+
3MFUA:CASK-4M CAM KINASE DOMAIN, AMPPNP-MN2+
3NYXA:NON-PHOSPHORYLATED TYK2 JH1 DOMAIN WITH QUINOLINE-THIADIAZOLE-THIOPHENE INHIBITOR
3NZ0A:NON-PHOSPHORYLATED TYK2 KINASE WITH CMP6
3ORXA:; B:; C:; D:; E:; F:; G:; H:PDK1 MUTANT BOUND TO ALLOSTERIC DISULFIDE FRAGMENT INHIBITOR 1F8
3ORZA:; B:; C:; D:PDK1 MUTANT BOUND TO ALLOSTERIC DISULFIDE FRAGMENT ACTIVATOR 2A2
3OTUA:PDK1 MUTANT BOUND TO ALLOSTERIC DISULFIDE FRAGMENT ACTIVATOR JS30
3PJCA:CRYSTAL STRUCTURE OF JAK3 COMPLEXED WITH A POTENT ATP SITE INHIBITOR SHOWING HIGH SELECTIVITY WITHIN THE JANUS KINASE FAMILY
3PPKA:; B:HUMAN B-RAF KINASE IN COMPLEX WITH A NON-OXIME FUROPYRIDINE INHIBITOR
3Q32A:; B:STRUCTURE OF JANUS KINASE 2 WITH A PYRROLOTRIAZINE INHIBITOR
3Q4TA:; B:CRYSTAL STRUCTURE OF ACTIVIN RECEPTOR TYPE-IIA (ACVR2A) KINASE DOMAIN IN COMPLEX WITH DORSOMORPHIN
3Q96A:; B:B-RAF KINASE DOMAIN IN COMPLEX WITH A TETRAHYDRONAPHTHALENE INHIBITOR
3QCQA:PHOSPHOINOSITIDE-DEPENDENT KINASE-1 (PDK1) KINASE DOMAIN WITH 6-(3-AMINO-1H-INDAZOL-6-YL)-N4-ETHYL-2,4-PYRIMIDINEDIAMINE
3QCSA:PHOSPHOINOSITIDE-DEPENDENT KINASE-1 (PDK1) KINASE DOMAIN WITH 6-[2-AMINO-6-(4-MORPHOLINYL)-4-PYRIMIDINYL]-1H-INDAZOL-3-AMINE
3QCXA:PHOSPHOINOSITIDE-DEPENDENT KINASE-1 (PDK1) KINASE DOMAIN WITH 6-{2-AMINO-6-[(3R)-3-METHYL-4-MORPHOLINYL]-4-PYRIMIDINYL}-1H-INDAZOL-3-AMINE
3QCYA:PHOSPHOINOSITIDE-DEPENDENT KINASE-1 (PDK1) KINASE DOMAIN WITH 4-[2-AMINO-6-(3-AMINO-1H-INDAZOL-6-YL)-4-PYRIMIDINYL]-N-PHENYL-2-MORPHOLINECARBOXAMIDE
3QD0A:PHOSPHOINOSITIDE-DEPENDENT KINASE-1 (PDK1) KINASE DOMAIN WITH (2R,5S)-1-[2-AMINO-6-(3-AMINO-1H-INDAZOL-6-YL)-4-PYRIMIDINYL]-6-METHYL-N-PHENYL-3-PIPERIDINECARBOXAMIDE
3QD3A:PHOSPHOINOSITIDE-DEPENDENT KINASE-1 (PDK1) KINASE DOMAIN WITH 1,1-DIMETHYLETHYL {(3R,6S)-1-[2-AMINO-6-(3-AMINO-1H-INDAZOL-6-YL)-4-PYRIMIDINYL]-6-METHYL-3-PIPERIDINYL}CARBAMATE
3QD4A:PHOSPHOINOSITIDE-DEPENDENT KINASE-1 (PDK1) KINASE DOMAIN WITH 1,1-DIMETHYLETHYL{(3R,5R)-1-[2-AMINO-6-(3-AMINO-1H-INDAZOL-6-YL)-4-PYRIMIDINYL]-5-METHYL-3-PIPERIDINYL}CARBAMATE
3REPA:CRYSTAL STRUCTURE OF THE ILK/ALPHA-PARVIN CORE COMPLEX (MNATP)
3RVGA:CRYSTALS STRUCTURE OF JAK2 WITH A 1-AMINO-5H-PYRIDO[4,3-B]INDOL-4-CARBOXAMIDE INHIBITOR
3SOCA:; B:CRYSTAL STRUCTURE OF ACTIVIN RECEPTOR TYPE-IIA (ACVR2A) KINASE DOMAIN IN COMPLEX WITH A QUINAZOLIN
3THBA:STRUCTURE OF PLK1 KINASE DOMAIN IN COMPLEX WITH A BENZOLACTAM-DERIVED INHIBITOR
3TJCA:; B:CO-CRYSTAL STRUCTURE OF JAK2 WITH THIENOPYRIDINE 8
3TJDA:; B:CO-CRYSTAL STRUCTURE OF JAK2 WITH THIENOPYRIDINE 19
3UGCA:STRUCTURAL BASIS OF JAK2 INHIBITION BY THE TYPE II INHIBTOR NVP-BBT594
3UIUA:; B:CRYSTAL STRUCTURE OF APO-PKR KINASE DOMAIN
3V5QA:; B:DISCOVERY OF A SELECTIVE TRK INHIBITOR WITH EFFICACY IN RODENT CANCER TUMOR MODELS
3VN9A:RIFINED CRYSTAL STRUCTURE OF NON-PHOSPHORYLATED MAP2K6 IN A PUTATIVE AUTO-INHIBITION STATE
3VQUA:CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH 4-[(4-AMINO-5-CYANO-6-ETHOXYPYRIDIN-2- YL)AMINO]BENZAMIDE
3VW6A:; B:CRYSTAL STRUCTURE OF HUMAN APOPTOSIS SIGNAL-REGULATING KINASE 1 (ASK1) WITH IMIDAZOPYRIDINE INHIBITOR
3W1FA:CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH 5-(5-ETHOXY-6-(1-METHYL-1H-PYRAZOL-4-YL)-1H-INDAZOL-3-YL)-2-METHYLBENZENESULFONAMIDE
3ZBFA:STRUCTURE OF HUMAN ROS1 KINASE DOMAIN IN COMPLEX WITH CRIZOTINIB
3ZDUA:CRYSTAL STRUCTURE OF THE HUMAN CDKL3 KINASE DOMAIN
3ZEPA:; B:; C:; D:CRYSTAL STRUCTURE OF JAK3 KINASE DOMAIN IN COMPLEX WITH A PYRROLOPYRAZINE-2-PHENYL ETHER INHIBITOR
3ZEWA:; B:CRYSTAL STRUCTURE OF EPHB4 IN COMPLEX WITH STAUROSPORINE
3ZFMA:CRYSTAL STRUCTURE OF EPHB2
3ZFXA:; B:; C:; D:; E:; F:; G:; H:; I:CRYSTAL STRUCTURE OF EPHB1
3ZFYA:; B:CRYSTAL STRUCTURE OF EPHB3
3ZH8A:; B:; C:A NOVEL SMALL MOLECULE APKC INHIBITOR
3ZHPC:; D:HUMAN MST3 (STK24) IN COMPLEX WITH MO25BETA
3ZMMA:; B:INHIBITORS OF JAK2 KINASE DOMAIN
3ZOSA:; B:STRUCTURE OF THE DDR1 KINASE DOMAIN IN COMPLEX WITH PONATINIB
3ZVVA:726-1092FRAGMENT BOUND TO PI3KINASE GAMMA
3ZW3A:726-1090FRAGMENT BASED DISCOVERY OF A NOVEL AND SELECTIVE PI3 KINASE INHIBITOR
3ZZWA:; B:CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF ROR2
4A06A:HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH ALLOSTERIC ACTIVATOR PS114 BOUND TO THE PIF-POCKET
4A07A:HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH ALLOSTERIC ACTIVATOR PS171 BOUND TO THE PIF-POCKET
4A4LA:CRYSTAL STRUCTURE OF POLO-LIKE KINASE 1 IN COMPLEX WITH A 5-(2-AMINO-PYRIMIDIN-4-YL)-1H-PYRROLE INHIBITOR
4A4OA:CRYSTAL STRUCTURE OF POLO-LIKE KINASE 1 IN COMPLEX WITH A 2-(2-AMINO-PYRIMIDIN-4-YL)-1,5,6,7-TETRAHYDRO-PYRROLOPYRIDIN-4-ONE INHIBITOR
4A7CA:CRYSTAL STRUCTURE OF PIM1 KINASE WITH ETP46546
4A9RA:CRYSTAL STRUCTURE OF HUMAN CHK2 IN COMPLEX WITH BENZIMIDAZOLE CARBOXAMIDE INHIBITOR
4A9SA:CRYSTAL STRUCTURE OF HUMAN CHK2 IN COMPLEX WITH BENZIMIDAZOLE CARBOXAMIDE INHIBITOR
4A9TA:CRYSTAL STRUCTURE OF HUMAN CHK2 IN COMPLEX WITH BENZIMIDAZOLE CARBOXAMIDE INHIBITOR
4A9UA:CRYSTAL STRUCTURE OF HUMAN CHK2 IN COMPLEX WITH BENZIMIDAZOLE CARBOXAMIDE INHIBITOR
4AAAA:CRYSTAL STRUCTURE OF THE HUMAN CDKL2 KINASE DOMAIN
4AGUA:; B:; C:CRYSTAL STRUCTURE OF THE HUMAN CDKL1 KINASE DOMAIN
4ALVA:BENZOFUROPYRIMIDINONE INHIBITORS OF PIM-1
4ALWA:BENZOFUROPYRIMIDINONE INHIBITORS OF PIM-1
4ANLA:STRUCTURE OF G1269A MUTANT ANAPLASTIC LYMPHOMA KINASE
4ANQA:STRUCTURE OF G1269A MUTANT ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH CRIZOTINIB
4ANSA:STRUCTURE OF L1196M,G1269A DOUBLE MUTANT ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH CRIZOTINIB
4ANUA:726-1087COMPLEXES OF PI3KGAMMA WITH ISOFORM SELECTIVE INHIBITORS.
4ANVA:726-1089COMPLEXES OF PI3KGAMMA WITH ISOFORM SELECTIVE INHIBITORS.
4ANWA:726-1087COMPLEXES OF PI3KGAMMA WITH ISOFORM SELECTIVE INHIBITORS.
4ANXA:726-1087COMPLEXES OF PI3KGAMMA WITH ISOFORM SELECTIVE INHIBITORS.
4AOJA:; B:; C:HUMAN TRKA IN COMPLEX WITH THE INHIBITOR AZ-23
4APCA:; B:CRYSTAL STRUCTURE OF HUMAN NIMA-RELATED KINASE 1 (NEK1)
4APPA:CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 4 IN COMPLEX WITH (S)-N-(5-(3-BENZYL-1-METHYLPIPERAZINE-4-CARBONYL)-6,6-DIMETHYL-1,4,5,6-TETRAHYDROPYRROLO(3,4-C) PYRAZOL-3-YL)-3-PHENOXYBENZAMIDE
4AQCA:; B:TRIAZOLOPYRIDINE-BASED INHIBITOR OF JANUS KINASE 2
4ASXA:; B:CRYSTAL STRUCTURE OF ACTIVIN RECEPTOR TYPE-IIA (ACVR2A) KINASE DOMAIN IN COMPLEX WITH DIHYDRO-BAUERINE C
4ASZA:CRYSTAL STRUCTURE OF APO TRKB KINASE DOMAIN
4AT3A:CRYSTAL STRUCTURE OF TRKB KINASE DOMAIN IN COMPLEX WITH CPD5N
4AT4A:CRYSTAL STRUCTURE OF TRKB KINASE DOMAIN IN COMPLEX WITH EX429
4AT5A:CRYSTAL STRUCTURE OF TRKB KINASE DOMAIN IN COMPLEX WITH GW2580
4AW0A:HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH ALLOSTERIC COMPOUND PS182 BOUND TO THE PIF-POCKET
4AW1A:HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH ALLOSTERIC COMPOUND PS210 BOUND TO THE PIF-POCKET
4AW5A:COMPLEX OF THE EPHB4 KINASE DOMAIN WITH AN OXINDOLE INHIBITOR
4B6LA:DISCOVERY OF ORAL POLO-LIKE KINASE (PLK) INHIBITORS WITH ENHANCED SELECTIVITY PROFILE USING RESIDUE TARGETED DRUG DESIGN
4B99A:CRYSTAL STRUCTURE OF MAPK7 (ERK5) WITH INHIBITOR
4B9DA:; B:CRYSTAL STRUCTURE OF HUMAN NIMA-RELATED KINASE 1 (NEK1) WITH INHIBITOR.
4BB4A:EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
4BBEA:; B:; C:; D:AMINOALKYLPYRIMIDINE INHIBITOR COMPLEXES WITH JAK2
4BBFA:; B:; C:; D:AMINOALKYLPYRIMIDINE INHIBITOR COMPLEXES WITH JAK2
4BBMA:; B:CRYSTAL STRUCTURE OF THE HUMAN CDKL2 KINASE DOMAIN WITH BOUND TCS 2312
4BDAA:FRAGMENT-BASED SCREENING IDENTIFIES A NEW AREA FOR INHIBITOR BINDING TO CHECKPOINT KINASE 2 (CHK2)
4BDBA:FRAGMENT-BASED SCREENING IDENTIFIES A NEW AREA FOR INHIBITOR BINDING TO CHECKPOINT KINASE 2 (CHK2)
4BDCA:FRAGMENT-BASED SCREENING IDENTIFIES A NEW AREA FOR INHIBITOR BINDING TO CHECKPOINT KINASE 2 (CHK2)
4BDDA:FRAGMENT-BASED SCREENING IDENTIFIES A NEW AREA FOR INHIBITOR BINDING TO CHECKPOINT KINASE 2 (CHK2)
4BDEA:FRAGMENT-BASED SCREENING IDENTIFIES A NEW AREA FOR INHIBITOR BINDING TO CHECKPOINT KINASE 2 (CHK2)
4BDFA:FRAGMENT-BASED SCREENING IDENTIFIES A NEW AREA FOR INHIBITOR BINDING TO CHECKPOINT KINASE 2 (CHK2)
4BDGA:FRAGMENT-BASED SCREENING IDENTIFIES A NEW AREA FOR INHIBITOR BINDING TO CHECKPOINT KINASE 2 (CHK2)
4BDHA:FRAGMENT-BASED SCREENING IDENTIFIES A NEW AREA FOR INHIBITOR BINDING TO CHECKPOINT KINASE 2 (CHK2)
4BDIA:FRAGMENT-BASED SCREENING IDENTIFIES A NEW AREA FOR INHIBITOR BINDING TO CHECKPOINT KINASE 2 (CHK2)
4BDJA:FRAGMENT-BASED SCREENING IDENTIFIES A NEW AREA FOR INHIBITOR BINDING TO CHECKPOINT KINASE 2 (CHK2)
4BF2A:; B:CRYSTAL STRUCTURES OF ASK1-INHIBITOR COMPLEXES
4BGQA:CRYSTAL STRUCTURE OF THE HUMAN CDKL5 KINASE DOMAIN
4BHNA:; B:CRYSTAL STRUCTURES OF ASK1-INHIBITOR COMPLEXES
4BHZA:SCAFFOLD FOCUSED VIRTUAL SCREENING: PROSPECTIVE APPLICATION TO THE DISCOVERY OF TTK INHIBITOR
4BI0A:SCAFFOLD FOCUSED VIRTUAL SCREENING: PROSPECTIVE APPLICATION TO THE DISCOVERY OF TTK INHIBITOR
4BI1A:SCAFFOLD FOCUSED VIRTUAL SCREENING: PROSPECTIVE APPLICATION TO THE DISCOVERY OF TTK INHIBITOR
4BI2A:SCAFFOLD FOCUSED VIRTUAL SCREENING: PROSPECTIVE APPLICATION TO THE DISCOVERY OF TTK INHIBITOR
4BIBA:; B:CRYSTAL STRUCTURES OF ASK1-INHIBITOR COMPLEXES
4BICA:; B:CRYSTAL STRUCTURES OF ASK1-INHIBITOR COMPLEXES
4BIDA:; B:CRYSTAL STRUCTURES OF ASK1-INHIBITOR COMPLEXES
4BIEA:; B:CRYSTAL STRUCTURES OF ASK1-INHIBITOR COMPLEXES
4BKJA:; B:CRYSTAL STRUCTURE OF THE HUMAN DDR1 KINASE DOMAIN IN COMPLEX WITH IMATINIB
4BN1A:CRYSTAL STRUCTURE OF V174M MUTANT OF AURORA-A KINASE
4BTJA:; B:TTBK1 IN COMPLEX WITH ATP
4BTKA:TTBK1 IN COMPLEX WITH INHIBITOR
4BTMA:; B:TTBK1 IN COMPLEX WITH INHIBITOR
4C4EA:STRUCTURE-BASED DESIGN OF ORALLY BIOAVAILABLE PYRROLOPYRIDINE INHIBITORS OF THE MITOTIC KINASE MPS1
4C4FA:STRUCTURE-BASED DESIGN OF ORALLY BIOAVAILABLE PYRROLOPYRIDINE INHIBITORS OF THE MITOTIC KINASE MPS1
4C4GA:STRUCTURE-BASED DESIGN OF ORALLY BIOAVAILABLE PYRROLOPYRIDINE INHIBITORS OF THE MITOTIC KINASE MPS1
4C4HA:STRUCTURE-BASED DESIGN OF ORALLY BIOAVAILABLE PYRROLOPYRIDINE INHIBITORS OF THE MITOTIC KINASE MPS1
4C4IA:STRUCTURE-BASED DESIGN OF ORALLY BIOAVAILABLE PYRROLOPYRIDINE INHIBITORS OF THE MITOTIC KINASE MPS1
4C4JA:STRUCTURE-BASED DESIGN OF ORALLY BIOAVAILABLE PYRROLOPYRIDINE INHIBITORS OF THE MITOTIC KINASE MPS1
4C61A:; B:INHIBITORS OF JAK2 KINASE DOMAIN
4C62A:; B:INHIBITORS OF JAK2 KINASE DOMAIN
4CCBA:STRUCTURE OF THE HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH 3-((R)-1-(5-FLUORO-2-(2H-1,2,3-TRIAZOL-2-YL) PHENYL)ETHOXY)-5-(5-METHYL-1H-PYRAZOL-4-YL)PYRIDIN-2-AMINE
4CCUA:STRUCTURE OF THE HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH 2-(5-(6-AMINO-5-((R)-1-(5-FLUORO-2-(2H-1,2,3-TRIAZOL-2-YL) PHENYL)ETHOXY)PYRIDIN-3-YL)-4-METHYLTHIAZOL-2-YL)PROPAN-2-OL
4CD0A:STRUCTURE OF L1196M MUTANT HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH 2-(5-(6-AMINO-5-((R)-1-(5-FLUORO-2-(2H-1,2,3-TRIAZOL-2-YL) PHENYL)ETHOXY)PYRIDIN-3-YL)-4-METHYLTHIAZOL-2-YL)PROPANE-1,2-DIOL
4CKIA:CRYSTAL STRUCTURE OF ONCOGENIC RET TYROSINE KINASE M918T BOUND TO ADENOSINE
4CKJA:CRYSTAL STRUCTURE OF RET TYROSINE KINASE DOMAIN BOUND TO ADENOSINE
4CKRA:CRYSTAL STRUCTURE OF THE HUMAN DDR1 KINASE DOMAIN IN COMPLEX WITH DDR1-IN-1
4CRSA:HUMAN PROTEIN KINASE N2 (PKN2, PRKCL2) IN COMPLEX WITH ATPGAMMAS
4D9TA:RSK2 C-TERMINAL KINASE DOMAIN WITH INHIBITOR (E)-METHYL 3-(4-AMINO-7-(3-HYDROXYPROPYL)-5-P-TOLYL-7H-PYRROLO[2,3-D]PYRIMIDIN-6-YL)-2-CYANOACRYLATE
4DCEA:; B:CRYSTAL STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH A PIPERIDINE-CARBOXAMIDE INHIBITOR
4E4LA:; B:; D:; E:JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 30
4E4MA:; B:; D:; E:JAK2 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 30
4E4NA:; B:JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 49
4E5WA:; B:JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 26
4E6DA:; B:JAK2 KINASE (JH1 DOMAIN) TRIPLE MUTANT IN COMPLEX WITH COMPOUND 7
4E6QA:; B:JAK2 KINASE (JH1 DOMAIN) TRIPLE MUTANT IN COMPLEX WITH COMPOUND 12
4EHZA:; B:; C:; D:THE JAK1 KINASE DOMAIN IN COMPLEX WITH INHIBITOR
4EI4A:; B:JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 20
4F08A:; B:DISCOVERY AND OPTIMIZATION OF C-2 METHYL IMIDAZO-PYRROLOPYRIDINES AS POTENT AND ORALLY BIOAVAILABLE JAK1 INHIBITORS WITH SELECTIVITY OVER JAK2
4F09A:DISCOVERY AND OPTIMIZATION OF C-2 METHYL IMIDAZO-PYRROLOPYRIDINES AS POTENT AND ORALLY BIOAVAILABLE JAK1 INHIBITORS WITH SELECTIVITY OVER JAK2
4F0IA:; B:CRYSTAL STRUCTURE OF APO TRKA
4FIGA:; B:CATALYTIC DOMAIN OF HUMAN PAK4
4FIHA:CATALYTIC DOMAIN OF HUMAN PAK4 WITH QKFTGLPRQW PEPTIDE
4FIJA:CATALYTIC DOMAIN OF HUMAN PAK4
4FK3A:; B:B-RAF KINASE V600E ONCOGENIC MUTANT IN COMPLEX WITH PLX3203
4FK6A:; B:JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 72
4FNWA:CRYSTAL STRUCTURE OF THE APO F1174L ANAPLASTIC LYMPHOMA KINASE CATALYTIC DOMAIN
4FNXA:CRYSTAL STRUCTURE OF THE APO R1275Q ANAPLASTIC LYMPHOMA KINASE CATALYTIC DOMAIN
4FNYA:CRYSTAL STRUCTURE OF THE R1275Q ANAPLASTIC LYMPHOMA KINASE CATALYTIC DOMAIN IN COMPLEX WITH A BENZOXAZOLE INHIBITOR
4FNZA:CRYSTAL STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH PIPERIDINE-CARBOXAMIDE INHIBITOR 2
4FOBA:CRYSTAL STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH ACYLIMINOBENZIMIDAZOLE INHIBITOR 1
4FOCA:CRYSTAL STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH ACYLIMINOBENZIMIDAZOLE INHIBITOR 2
4FODA:CRYSTAL STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH ACYLIMINOBENZIMIDAZOLE INHIBITOR 36
4FVPA:CRYSTAL STRUCTURE OF THE JAK2 PSEUDOKINASE DOMAIN (APO FORM)
4FVQA:CRYSTAL STRUCTURE OF THE JAK2 PSEUDOKINASE DOMAIN (MG-ATP-BOUND FORM)
4FVRA:CRYSTAL STRUCTURE OF THE JAK2 PSEUDOKINASE DOMAIN MUTANT V617F (MG-ATP-BOUND FORM)
4FZAB:CRYSTAL STRUCTURE OF MST4-MO25 COMPLEX
4G2FA:HUMAN EPHA3 KINASE DOMAIN IN COMPLEX WITH COMPOUND 7
4G31A:CRYSTAL STRUCTURE OF GSK6414 BOUND TO PERK (R587-R1092, DELETE A660-T867) AT 2.28 A RESOLUTION
4G34A:CRYSTAL STRUCTURE OF GSK6924 BOUND TO PERK (R587-R1092, DELETE A660-T867) AT 2.70 A RESOLUTION
4GFMA:JAK2 KINASE (JH1 DOMAIN) WITH 2,6-DICHLORO-N-(2-OXO-2,5-DIHYDROPYRIDIN-4-YL)BENZAMIDE
4GFOA:TYK2 KINASE (JH1 DOMAIN) WITH 2,6-DICHLORO-N-(2-OXO-2,5-DIHYDROPYRIDIN-4-YL)BENZAMIDE
4GIHA:TYK2 (JH1) IN COMPLEX WITH 2,6-DICHLORO-N-{2-[(CYCLOPROPYLCARBONYL) AMINO]PYRIDIN-4-YL}BENZAMIDE
4GIIA:TYK2 (JH1) IN COMPLEX WITH 2,6-DICHLORO-4-CYANO-N-{2-[(CYCLOPROPYLCARBONYL)AMINO]PYRIDIN-4-YL}BENZAMIDE
4GJ2A:TYK2 (JH1) IN COMPLEX WITH 2,6-DICHLORO-N-[2-({[(1R,2R)-2-FLUOROCYCLOPROPYL]CARBONYL}AMINO)PYRIDIN-4-YL]BENZAMIDE
4GJ3A:TYK2 (JH1) IN COMPLEX WITH 2,6-DICHLORO-4-CYANO-N-[2-({[(1R,2R)-2-FLUOROCYCLOPROPYL]CARBONYL}AMINO)PYRIDIN-4-YL]BENZAMIDE
4GK2A:HUMAN EPHA3 KINASE DOMAIN IN COMPLEX WITH LIGAND 66
4GK3A:HUMAN EPHA3 KINASE DOMAIN IN COMPLEX WITH LIGAND 87
4GK4A:HUMAN EPHA3 KINASE DOMAIN IN COMPLEX WITH LIGAND 90
4GMYA:JAK2 KINASE (JH1 DOMAIN) IN COMPLEX WITH 2,6-DICHLORO-N-{2-[(CYCLOPROPYLCARBONYL)AMINO]PYRIDIN-4-YL}BENZAMIDE
4GT4A:; B:STRUCTURE OF UNLIGANDED, INACTIVE ROR2 KINASE DOMAIN
4GT5A:CRYSTAL STRUCTURE OF THE INACTIVE TRKA KINASE DOMAIN
4GVJA:TYK2 (JH1) IN COMPLEX WITH ADENOSINE DI-PHOSPHATE
4HGEA:; B:JAK2 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 8
4HLEA:726-1092COMPOUND 21 (1-ALKYL-SUBSTITUTED 1,2,4-TRIAZOLES)
4HVDA:JAK3 KINASE DOMAIN IN COMPLEX WITH 2-CYCLOPROPYL-5H-PYRROLO[2,3-B]PYRAZINE-7-CARBOXYLIC ACID ((S)-1,2,2-TRIMETHYL-PROPYL)-AMIDE
4HVGA:JAK3 KINASE DOMAIN IN COMPLEX WITH 2-CYCLOPROPYL-5H-PYRROLO[2,3-B]PYRAZINE-7-CARBOXYLIC ACID ((S)-2-HYDROXY-1,2-DIMETHYL-PROPYL)-AMIDE
4HVHA:JAK3 KINASE DOMAIN IN COMPLEX WITH 2-CYCLOPROPYL-5H-PYRROLO[2,3-B]PYRAZINE-7-CARBOXYLIC ACID ((R)-2-HYDROXY-1,2-DIMETHYL-PROPYL
4HVIA:JAK3 KINASE DOMAIN IN COMPLEX WITH 2-CYCLOPROPYL-5H-PYRROLO[2,3-B]PYRAZINE-7-CARBOXYLIC ACID ((R)-1-METHYL-2-OXO-2-PIPERIDIN-1-YL-ETHYL)-AMIDE
4I5CA:; B:THE JAK1 KINASE DOMAIN IN COMPLEX WITH INHIBITOR
4I5PA:SELECTIVE & BRAIN-PERMEABLE POLO-LIKE KINASE-2 (PLK-2) INHIBITORS THAT REDUCE -SYNUCLEIN PHOSPHORYLATION IN RAT BRAIN
4I6BA:SELECTIVE & BRAIN-PERMEABLE POLO-LIKE KINASE-2 (PLK-2) INHIBITORS THAT REDUCE -SYNUCLEIN PHOSPHORYLATION IN RAT BRAIN
4I6FA:SELECTIVE & BRAIN-PERMEABLE POLO-LIKE KINASE-2 (PLK-2) INHIBITORS THAT REDUCE -SYNUCLEIN PHOSPHORYLATION IN RAT BRAIN
4I6HA:SELECTIVE & BRAIN-PERMEABLE POLO-LIKE KINASE-2 (PLK-2) INHIBITORS THAT REDUCE ALPHA-SYNUCLEIN PHOSPHORYLATION IN RAT BRAIN
4I6QA:JAK3 KINASE DOMAIN IN COMPLEX WITH 2-PHENOXY-5H-PYRROLO[2,3-B]PYRAZINE-7-CARBOXYLIC ACID ((S)-1-CYCLOPROPYL-ETHYL)-AMIDE
4IC7A:; D:CRYSTAL STRUCTURE OF THE ERK5 KINASE DOMAIN IN COMPLEX WITH AN MKK5 BINDING FRAGMENT
4IC8A:; B:CRYSTAL STRUCTURE OF THE APO ERK5 KINASE DOMAIN
4ITHA:; B:CRYSTAL STRUCTURE OF RIP1 KINASE IN COMPLEX WITH NECROSTATIN-1 ANALOG
4ITIA:; B:CRYSTAL STRUCTURE OF RIP1 KINASE IN COMPLEX WITH NECROSTATIN-3 ANALOG
4ITJA:; B:CRYSTAL STRUCTURE OF RIP1 KINASE IN COMPLEX WITH NECROSTATIN-4
4IVAA:JAK2 KINASE (JH1 DOMAIN) IN COMPLEX WITH THE INHIBITOR TRANS-4-[(8AS)-2-[(1R)-1-HYDROXYETHYL]IMIDAZO[4,5-D]PYRROLO[2,3-B]PYRIDIN-1(8AH)-YL]CYCLOHEXANECARBONITRILE
4IVBA:; B:JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH THE INHIBITOR TRANS-4-{2-[(1R)-1-HYDROXYETHYL]IMIDAZO[4,5-D]PYRROLO[2,3-B]PYRIDIN-1(6H)-YL}CYCLOHEXANECARBONITRILE
4IVCA:; B:JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH THE INHIBITOR (TRANS-4-{2-[(1R)-1-HYDROXYETHYL]IMIDAZO[4,5-D]PYRROLO[2,3-B]PYRIDIN-1(6H)-YL}CYCLOHEXYL)ACETONITRILE
4IVDA:; B:JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 34
4J52A:CRYSTAL STRUCTURE OF PLK1 IN COMPLEX WITH A PYRIMIDODIAZEPINONE INHIBITOR
4J53A:CRYSTAL STRUCTURE OF PLK1 IN COMPLEX WITH TAK-960
4J6IA:726-1087DISCOVERY OF THIAZOLOBENZOXEPIN PI3-KINASE INHIBITORS THAT SPARE THE PI3-KINASE BETA ISOFORM
4JDHA:CRYSTAL STRUCTURE OF SERINE/THREONINE-PROTEIN KINASE PAK 4 IN COMPLEX WITH PAKTIDE T PEPTIDE SUBSTRATE
4JDIA:CRYSTAL STRUCTURE OF SERINE/THREONINE-PROTEIN KINASE PAK 4 IN COMPLEX WITH PAKTIDE S PEPTIDE SUBSTRATE
4JDJA:CRYSTAL STRUCTURE OF SERINE/THREONINE-PROTEIN KINASE PAK 4 F461V MUTANT IN COMPLEX WITH PAKTIDE T PEPTIDE SUBSTRATE
4JDKA:CRYSTAL STRUCTURE OF SERINE/THREONINE-PROTEIN KINASE PAK 4 F461V MUTANT IN COMPLEX WITH PAKTIDE S PEPTIDE SUBSTRATE
4JI9A:; B:JAK2 KINASE (JH1 DOMAIN) IN COMPLEX WITH TG101209
4JIAA:JAK2 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 9
4JOAA:CRYSTAL STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH 7-AZAINDOLE BASED INHIBITOR
4JS8A:CRYSTAL STRUCTURE OF TTK KINASE DOMAIN WITH AN INHIBITOR: 401348
4JT3A:CRYSTAL STRUCTURE OF TTK KINASE DOMAIN WITH AN INHIBITOR: 400740
4JVGA:; B:; C:; D:B-RAF KINASE IN COMPLEX WITH BIRB796
4JXFA:CRYSTAL STRUCTURE OF PLK4 KINASE WITH AN INHIBITOR: 400631 ((1R,2S)-2-{3-[(E)-2-{4-[(DIMETHYLAMINO)METHYL]PHENYL}ETHENYL]-2H-INDAZOL-6-YL}-5'-METHOXYSPIRO[CYCLOPROPANE-1,3'-INDOL]-2'(1'H)-ONE)
4K6ZA:THE JAK1 KINASE DOMAIN IN COMPLEX WITH COMPOUND 37
4K77A:; B:JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 6
4KS7A:PAK6 KINASE DOMAIN IN COMPLEX WITH PF-3758309
4KS8A:PAK6 KINASE DOMAIN IN COMPLEX WITH SUNITINIB
4L00A:; B:CRYSTAL STRUCTURE OF THE APO JAK1 PSEUDOKINASE DOMAIN
4L01A:; B:CRYSTAL STRUCTURE OF THE V658F APO JAK1 PSEUDOKINASE DOMAIN
4L3JA:CRYSTAL STRUCTURES OF HUMAN P70S6K1 KINASE DOMAIN
4L3LA:CRYSTAL STRUCTURES OF HUMAN P70S6K1 KINASE DOMAIN (ZINC ANOMALOUS)
4L42A:CRYSTAL STRUCTURES OF HUMAN P70S6K1-PIF
4L43A:CRYSTAL STRUCTURES OF HUMAN P70S6K1-T389A (FORM I)
4L44A:CRYSTAL STRUCTURES OF HUMAN P70S6K1-T389A (FORM II)
4L45A:CRYSTAL STRUCTURES OF HUMAN P70S6K1-T389E
4L46A:CRYSTAL STRUCTURES OF HUMAN P70S6K1-WT
4L67A:CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF PAK4
4LG4A:; B:; C:; D:; E:; F:STRUCTURAL BASIS FOR AUTOACTIVATION OF HUMAN MST2 KINASE AND ITS REGULATION BY RASSF5
4M67A:CRYSTAL STRUCTURE OF THE HUMAN MLKL KINASE-LIKE DOMAIN
4MKCA:CRYSTAL STRUCTURE OF ANAPLASTIC LYMPHOMA KINASE COMPLEXED WITH LDK378
4MWIA:CRYSTAL STRUCTURE OF THE HUMAN MLKL PSEUDOKINASE DOMAIN
4NFMA:HUMAN TAU TUBULIN KINASE 1 (TTBK1)
4NFNA:HUMAN TAU TUBULIN KINASE 1 (TTBK1) COMPLEXED WITH 3-({5-[(4-AMINO-4-METHYLPIPERIDIN-1-YL)METHYL]PYRROLO[2,1-F][1,2,4]TRIAZIN-4-YL}AMINO)-5-BROMOPHENOL
4NUSA:RSK2 N-TERMINAL KINASE IN COMPLEX WITH LJH685
4NW5A:51-346RSK2 N-TERMINAL KINASE IN COMPLEX WITH 2-AMINO-7-SUBSTITUTED BENZOXAZOLE COMPOUND 8
4NW6A:51-346RSK2 N-TERMINAL KINASE IN COMPLEX WITH 2-AMINO-7-SUBSTITUTED BENZOXAZOLE COMPOUND 27
4O0RA:; B:BACK POCKET FLEXIBILITY PROVIDES GROUP-II PAK SELECTIVITY FOR TYPE 1 KINASE INHIBITORS
4O0TA:; B:BACK POCKET FLEXIBILITY PROVIDES GROUP-II PAK SELECTIVITY FOR TYPE 1 KINASE INHIBITORS
4O0VA:BACK POCKET FLEXIBILITY PROVIDES GROUP-II PAK SELECTIVITY FOR TYPE 1 KINASE INHIBITORS
4O0XA:BACK POCKET FLEXIBILITY PROVIDES GROUP-II PAK SELECTIVITY FOR TYPE 1 KINASE INHIBITORS
4O0YA:BACK POCKET FLEXIBILITY PROVIDES GROUP-II PAK SELECTIVITY FOR TYPE 1 KINASE INHIBITORS
4OTWA:HER3 PSEUDOKINASE DOMAIN BOUND TO BOSUTINIB